Enzo BiochemENZB
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 39 institutions reported holding Enzo Biochem Inc. (ENZB) in their 13F filings, down 2 from Q1 2024. 4 opened new positions and 6 sold out. The largest holders were Harbert Fund Advisors, LLC ($5.6M), Renaissance Technologies ($2.7M) and Vanguard Group Inc. ($2.0M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Enzo Biochem Inc.
- CUSIP
- 294100102
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $105K |
| Exits | 6 | $1.7M |
All 13F filers, Q1 2024 → Q2 2024: 323,918 shares bought and 1,766,453 shares sold, net −1,442,535 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Harbert Fund Advisors, LLC | 4.53% | No change | 5,175,913 | $5.6M |
| Renaissance Technologies | 0.00% | Add +2.6% | 2,499,546 | $2.7M |
| Vanguard Group Inc. | 0.00% | No change | 1,876,622 | $2.0M |
| BlackRock Inc. | 0.00% | Add +0.1% | 955,023 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +5.6% | 356,904 | $389K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -48.1% | 340,333 | $371K |
| RBF Capital, LLC | 0.02% | No change | 250,359 | $273K |
| State Street Corp. | 0.00% | No change | 154,139 | $168K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -41.8% | 132,100 | $144K |
| Wittenberg Investment Management, Inc. | 0.04% | Add +72.3% | 117,137 | $128K |
| Nierenberg Investment Management Company, LLC | 0.06% | Add +666.4% | 88,555 | $97K |
| Morgan Stanley | 0.00% | No change | 71,755 | $78K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 67,204 | $73K |
| Lazard Asset Management LLC | 0.00% | New | 50,453 | $54K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 44,800 | $49K |
| XTX Topco Ltd | 0.00% | Add +94.5% | 28,262 | $31K |
| Kempner Capital Management Inc. | 0.01% | No change | 25,475 | $28K |
| Assenagon Asset Management S.A. | 0.00% | No change | 19,773 | $22K |
| Millennium Management | 0.00% | New | 19,363 | $21K |
| Raymond James Trust N.A. | 0.00% | No change | 17,016 | $19K |
| Shulman DeMeo Asset Management LLC | 0.00% | No change | 15,487 | $17K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 14,955 | $16K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 13,471 | $15K |
| TLS Advisors LLC | 0.04% | New | 13,616 | $14K |
| Snowden Capital Advisors LLC | 0.00% | Reduce -41.1% | 12,045 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -64.8% | 4,263 | $5K |
| Covestor Ltd | 0.00% | No change | 3,967 | $4K |
| Bfsg, LLC | 0.00% | No change | 2,813 | $3K |
| Bank of America Corp. | 0.00% | Reduce -7.3% | 2,214 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 1,833 | $2K |
| Royal Bank of Canada | 0.00% | No change | 1,081 | $1K |
| Simplex Trading, LLC | 0.00% | Add +81.7% | 1,601 | $1K |
| UBS Group AG | 0.00% | Add +160.1% | 723 | $788 |
| Wells Fargo & Company | 0.00% | Reduce -34.5% | 578 | $630 |
| FMR LLC | 0.00% | Reduce -78.4% | 429 | $468 |
| Clear Point Advisors Inc. | 0.00% | No change | 120 | $131 |
| Osaic Holdings, Inc. | 0.00% | Reduce -89.3% | 120 | $131 |
| Sound Income Strategies, LLC | 0.00% | No change | 10 | $11 |
| Benjamin Edwards Inc. | 0.00% | No change | 300 | $0 |
"% of holder's portfolio" is ENZB's weight in each manager's 13F, not the share of Enzo Biochem Inc. the manager owns.